This letter reports some observations on the recent article entitled "Meta-analysis of the prognostic value of CpG island methylator phenotype in gastric cancer" by Powell et al 1 (2018) reporting that gastric cancers showing CpG island methylator phenotype-high (CIMP-H) were associated with poor 5-year survival. The conclusion was reached by a well-conducted meta-analysis. However, as the authors claimed, there was significant heterogeneity among the 10 included studies (I 2 = 88%, P < .001), but they applied a fixed-effects model, which might limit the conclusion. As a result of a lack of a standardized definition of CIMP in gastric cancer, the authors noticed that the conflicting survival results might be caused by the choice of CIMP gene panel. Currently, gene-specific methylation markers and genomewide DNA methylation profile were the 2 major methods to define CIMP.
Ben Ayed-Guerfali et al, 5 He et al, 6 Ksiaa et al 7 ,
and Kusano et al 8 were classified as the p16 or MINT-based gene panel group, whereas the remaining 3 studies (Chang et al, 9 Chen et As a result of large heterogeneity, we then analyzed the data by the random-effects model. Surprisingly, in all 3 subgroups, CIMP-H did not have any association with poor 5-year survival (P > .05) (Figure 1B) . In summary, we may conclude that CIMP is not a prognostic marker in gastric cancer.
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